Provided by Tiger Trade Technology Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

14.38
+0.70005.12%
Pre-market: 15.631.25+8.67%04:51 EDT
Volume:3.44M
Turnover:49.58M
Market Cap:2.16B
PE:-3.21
High:14.86
Open:13.96
Low:13.92
Close:13.68
52wk High:18.57
52wk Low:7.48
Shares:150.42M
Float Shares:117.99M
Volume Ratio:1.51
T/O Rate:2.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4800
EPS(LYR):-6.8648
ROE:-799.46%
ROA:-71.98%
PB:176.98
PE(LYR):-2.09

Loading ...

Biohaven Cut to Underperform from Neutral by B of a Securities

Dow Jones
·
Jun 29

BofA Securities Downgrades Biohaven to Underperform From Neutral, $11 Price Target

MT Newswires Live
·
Jun 29

Biohaven Starts Pivotal Phase 3 Trial of Bhv-1300 in Graves' Disease

Reuters
·
Jun 29

Biohaven Advances a New Class of Precision Immunology Therapies: First Mode Extracellular Protein Degrader, Bhv-1300, Begins Phase 3 Pivotal Trial in Graves' Disease

THOMSON REUTERS
·
Jun 29

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Biohaven Ltd. (BHVN) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Jun 29

Biohaven rises 7.4%

TIPRANKS
·
Jun 26

U.S. Research Roundup-american Tower, H.B. Fuller Company, TD Synnex

Reuters
·
Jun 26

Biohaven's Troriluzole Could Drive Potential Upside if the Company Overcomes Regulatory Hurdles, RBC Says

MT Newswires Live
·
Jun 25

RBC Capital Sticks to Their Buy Rating for Biohaven Ltd. (BHVN)

TIPRANKS
·
Jun 25

Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX), Biohaven Ltd. (BHVN) and BioLife Solutions (BLFS)

TIPRANKS
·
Jun 25

Biohaven (BHVN) Is Up 22.2% After Advancing Multiple Immunology And Oncology Candidates To Pivotal Trials

Simply Wall St.
·
Jun 24

Analysts Are Bullish on These Healthcare Stocks: uniQure (QURE), Biohaven Ltd. (BHVN)

TIPRANKS
·
Jun 18

Acting US FDA chief meets with rare disease groups to mend fences

Reuters
·
Jun 04

Is Biohaven’s PKM2 and Autoimmune Pipeline Progress Altering The Investment Case For Biohaven (BHVN)?

Simply Wall St.
·
Jun 03

Biohaven Starts First Human Trial of BHV-8100 for Neurological, Retinal and Inflammatory Diseases

MT Newswires Live
·
Jun 01

Biohaven starts first-in-human Phase 1 trial of oral PKM2 modulator BHV-8100

Reuters
·
Jun 01

Analysts Are Bullish on These Healthcare Stocks: Biohaven Ltd. (BHVN), Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
May 30

Analysts Conflicted on These Healthcare Names: MannKind (MNKD), Biohaven Ltd. (BHVN) and Precision BioSciences (DTIL)

TIPRANKS
·
May 28

Canaccord Genuity Reaffirms Their Buy Rating on Biohaven Ltd. (BHVN)

TIPRANKS
·
May 28

Analysts Offer Insights on Healthcare Companies: Phreesia (PHR), McKesson (MCK) and Biohaven Ltd. (BHVN)

TIPRANKS
·
May 28